PF-Atlas › Исследования › Heart Failure
Исследования: Heart Failure (23)
23 публикаций в теме «Heart Failure», проиндексированных PF-Atlas из PubMed и мировых журналов.
Межзаболеваемые исследования. Эти работы относятся к смежным фибротическим, онкологическим или регенеративным областям и отслеживаются ради механистической значимости для ИЛФ. Они не являются прямым доказательством лечения идиопатического легочного фиброза.
- Lung Transplantation in Rheumatoid Arthritis Related Interstitial Lung Disease: Risk Factors and Mortality in a Universal Health Care System. · Clinical transplantation · 2026
- Pulmonary Hypertension Under the Microscope: What Histopathology Means for Diagnosis and Treatment. · Chest · 2026
- A Tight Squeeze - Cardiac Tamponade in a Scleroderma Patient. · Journal of community hospital internal medicine perspectives · 2026
- Clinical Presentation, Diagnosis, Treatment, and Outcome of Heart Disease in Becker Muscular Dystrophy. · Anatolian journal of cardiology · 2026
- Left Ventricular Diastolic Dysfunction in Patients with Interstitial Lung Disease-A Potential Treatable Trait. · Advances in respiratory medicine · 2026
- Prognostic value of the FIB-4 and FIB-5 indices in patients hospitalised for acute heart failure. Analysis of the RICA-2 registry. · Revista clinica espanola · 2026
- Primary myocardial involvement in systemic sclerosis: pathophysiology, clinical manifestations and advances in cardiac imaging. · Rheumatology (Oxford, England) · 2026
- Idiopathic Pulmonary Fibrosis: An Overview. · British journal of hospital medicine (London, England : 2005) · 2026
- A randomised open-label pilot trial comparing mycophenolate mofetil with no immunosuppression in limited cutaneous systemic sclerosis . · Rheumatology (Oxford, England) · 2026
- Seeing and sensing the heart: integrating non-coding RNA biomarkers with imaging in cardiovascular medicine. · European heart journal. Imaging methods and practice · 2026
- Clinical features and prognosis of idiopathic inflammatory myopathy complicated by heart failure with preserved ejection fraction. · Rheumatology (Oxford, England) · 2026
- Therapeutic potential of magnesium diboride nanosheets in PAH-associated right heart failure: Integrated multi-omics analysis reveals ferroptosis suppression via LC3/ATG5/NCOA4/FTH1 pathway. · Free radical biology & medicine · 2026
- Outcomes of beta-blocker use in people living with chronic obstructive pulmonary disease and a co-existent beta-blocker indicated cardiovascular disease. Insights from a global federated network. · BMC pulmonary medicine · 2026
- Systemic sclerosis and cardiovascular disease: an integrative perspective on immune-vascular mechanisms and emerging risk stratification strategies. · Rheumatology international · 2026
- Two-year outcomes of a cardiac microcurrent device in chronic heart failure: A first-in-human pilot study. · ESC heart failure · 2025
- Effects of empagliflozin on functional capacity, LV filling pressure, and cardiac reserves in patients with type 2 diabetes mellitus and heart failure with preserved ejection fraction: a randomized controlled open-label trial. · Cardiovascular diabetology · 2025
- Mode of death after venovenous extracorporeal membrane oxygenation - a retrospective single-center analysis. · Respiratory medicine · 2025
- Efficacy and safety of Nintedanib in idiopathic pulmonary fibrosis: A systematic review and meta-analysis. · Heart & lung : the journal of critical care · 2025
- Long-term outcomes and prognostic predictors in patients with fibrosing mediastinitis associated pulmonary hypertension: a multicenter cohort study. · Orphanet journal of rare diseases · 2025
- Atrial cardiomyopathy: From healthy atria to atrial failure. A clinical consensus statement of the Heart Failure Association of the ESC. · European journal of heart failure · 2025
- Right Ventricular Dynamics in Tricuspid Regurgitation: Insights into Reverse Remodeling and Outcome Prediction Post Transcatheter Valve Intervention. · International journal of molecular sciences · 2025
- Current landscape for connective tissue disease associated-pulmonary arterial hypertension: a focus on right ventricular adaptation and failure. · Future cardiology · 2025
- NT-proBNP <95 ng/l can exclude pulmonary hypertension on echocardiography at diagnostic workup in patients with interstitial lung disease. · European clinical respiratory journal · 2016
Медицинская оговорка. Списки исследований приведены только для информации и не являются медицинской рекомендацией.